Structure of the human κ-opioid receptor in complex with JDTic

被引:686
作者
Wu, Huixian [1 ]
Wacker, Daniel [1 ]
Mileni, Mauro [1 ]
Katritch, Vsevolod [1 ]
Han, Gye Won [1 ]
Vardy, Eyal [2 ,3 ]
Liu, Wei [1 ]
Thompson, Aaron A. [1 ]
Huang, Xi-Ping [2 ,3 ]
Carroll, F. Ivy [4 ]
Mascarella, S. Wayne [4 ]
Westkaemper, Richard B. [5 ]
Mosier, Philip D. [5 ]
Roth, Bryan L. [2 ,3 ]
Cherezov, Vadim [1 ]
Stevens, Raymond C. [1 ]
机构
[1] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[2] Univ N Carolina, Chapel Hill Med Sch, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Dept Pharmacol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Chapel Hill Med Sch, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA
[4] Res Triangle Inst, Ctr Organ & Med Chem, Res Triangle Pk, NC 27709 USA
[5] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA
关键词
PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; TRANSMEMBRANE DOMAIN; MEMBRANE-PROTEINS; OPIATE RECEPTOR; SALVINORIN-A; IN-VITRO; DOCKING; AGONIST; ANALOGS;
D O I
10.1038/nature10939
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Opioid receptors mediate the actions of endogenous and exogenous opioids on many physiological processes, including the regulation of pain, respiratory drive, mood, and-in the case of kappa-opioid receptor (kappa-OR)-dysphoria and psychotomimesis. Here we report the crystal structure of the human kappa-OR in complex with the selective antagonist JDTic, arranged in parallel dimers, at 2.9 angstrom resolution. The structure reveals important features of the ligand-binding pocket that contribute to the high affinity and subtype selectivity of JDTic for the human kappa-OR. Modelling of other important kappa-OR-selective ligands, including the morphinan-derived antagonists norbinaltorphimine and 5'-guanidinonaltrindole, and the diterpene agonist salvinorin A analogue RB-64, reveals both common and distinct features for binding these diverse chemotypes. Analysis of site-directed mutagenesis and ligand structure-activity relationships confirms the interactions observed in the crystal structure, thereby providing a molecular explanation for kappa-OR subtype selectivity, and essential insights for the design of compounds with new pharmacological properties targeting the human kappa-OR.
引用
收藏
页码:327 / U69
页数:8
相关论文
共 50 条
  • [1] PHENIX: a comprehensive Python']Python-based system for macromolecular structure solution
    Adams, Paul D.
    Afonine, Pavel V.
    Bunkoczi, Gabor
    Chen, Vincent B.
    Davis, Ian W.
    Echols, Nathaniel
    Headd, Jeffrey J.
    Hung, Li-Wei
    Kapral, Gary J.
    Grosse-Kunstleve, Ralf W.
    McCoy, Airlie J.
    Moriarty, Nigel W.
    Oeffner, Robert
    Read, Randy J.
    Richardson, David C.
    Richardson, Jane S.
    Terwilliger, Thomas C.
    Zwart, Peter H.
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2010, 66 : 213 - 221
  • [2] Ballesteros J. A., 1995, Neuroscience Methods, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471]
  • [3] Befort K, 1996, MOL PHARMACOL, V49, P216
  • [4] Bricogne G, 2009, BUSTER V 2 8 0
  • [5] Crystallizing membrane proteins using lipidic mesophases
    Caffrey, Martin
    Cherezov, Vadim
    [J]. NATURE PROTOCOLS, 2009, 4 (05) : 706 - 731
  • [6] Synthesis and in vitro opioid receptor functional antagonism of analogues of the selective kappa opioid receptor antagonist (3R)-7-Hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic)
    Cai, Tingwei Bill
    Zou, Zhou
    Thomas, James B.
    Brieaddy, Larry
    Navarro, Hernan A.
    Carroll, F. Ivy
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (06) : 1849 - 1860
  • [7] Kappa-opioid ligands in the study and treatment of mood disorders
    Carlezon, William A., Jr.
    Beguin, Cecile
    Knoll, Allison T.
    Cohen, Bruce M.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2009, 123 (03) : 334 - 343
  • [8] Pharmacological properties of JDTic:: a novel κ-opioid receptor antagonist
    Carroll, I
    Thomas, JB
    Dykstra, LA
    Granger, AL
    Allen, RM
    Howard, JL
    Pollard, GT
    Aceto, MD
    Harris, LS
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 501 (1-3) : 111 - 119
  • [9] SPECIFIC RECEPTOR FOR THE OPIOID PEPTIDE DYNORPHIN - STRUCTURE-ACTIVITY-RELATIONSHIPS
    CHAVKIN, C
    GOLDSTEIN, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (10): : 6543 - 6547
  • [10] Mutation of a single TMVI residue, Phe282, in the β2-adrenergic receptor results in structurally distinct activated receptor conformations
    Chen, SH
    Lin, F
    Xu, M
    Riek, RP
    Novotny, J
    Graham, RM
    [J]. BIOCHEMISTRY, 2002, 41 (19) : 6045 - 6053